NCT05736679

EaveTubes for Vector Control

Name: Clinical Trial NCT05736679
Creator: University of Notre Dame
Keywords: Malaria, In2Care EaveTube, device, clinical trial

EaveTubes for Control of Vector Borne Diseases in Côte d'Ivoire

University of Notre Dame·ClinicalTrials.gov·device·Device trialNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Malaria
Drug/Device/Intervention: In2Care EaveTube
Study type: Interventional
Intervention type: device

Sponsor & location

Primary sponsor: University of Notre Dame

Timeline & enrollment

Phase: N/A
Start date: Jul 01, 2023
End date: Jun 01, 2025
Enrollment: 1870 participants

Primary outcome

Incidence rate of malaria infection

Summary

The goal of this clinical trial is to test whether In2Care EaveTubes (ETs) as a stand-alone tool can reduce malaria in an area where transmission is driven by insecticide-resistant Anopheles gambiae. Children who live in homes with ETs will be monitored for malaria infection and compared to children living in homes without ETs in Côte d'Ivoire where there is universal coverage of long lasting insecticide nets and pyrethroid resistance is high.

ICD-10 classifications

Unspecified malariaPlasmodium malariae malariaPlasmodium falciparum malariaOther parasitologically confirmed malariaPlasmodium ovale malaria

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05736679
Type: Device Trial

About this record

Access comprehensive clinical trial information for NCT05736679 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Notre Dame and is currently Not yet recruiting. The study focuses on Malaria. Target enrollment is 1870 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.